Orchid Chemicals & Pharmaceuticals Ltd
Unaudited Financial Results for three months ended September 30, 2003
           
(Rs.Lakhs)
Sl No Particulars
Three months ended
September 30, 2003
(Unaudited)
Three months ended
September 30, 2002
(Unaudited)
Six months ended
September 30, 2003
(Unaudited)
Six months ended
September 30, 2002
(Unaudited)
Year ended March 31, 2003
(Audited)
1
 Sales and Operating Income
16183.32
11133.26
33475.39
21816.76
54141.43
2
 Other Income
14.69
28.27
64.58
30.87
111.38
3
 Total Expenditure
12288.35
8914.33
26321.63
17392.04
43289.70
a) Decrease/(Increase) in Stock in trade
(1985.78)
(3320.34)
(3161.82)
(3459.56)
(4702.99)
b) Consumption of raw materials
9305.15
8109.01
19872.53
13679.55
31910.92
c) Staff Cost
1208.82
765.27
2169.23
1518.69
3403.16
d) Other Expenditure
3760.16
3360.39
7441.69
5653.36
12678.61
4
Profit before Interest, Depreciation & Tax (1+2-3)
3909.66
2247.20
7218.34
4455.59
10963.11
5
 Interest and Finance Charges
1660.88
1032.99
2769.58
1789.61
4207.69
6
 Depreciation
1350.15
867.98
2730.21
1890.73
4030.71
7
 Profit before tax (4-5-6)
898.63
347.23
1718.55
775.25
2724.71
8
 Provision for Taxation
      Current Tax
36.96
-
100.05
-
      Deferred Tax
131.60
57.06
131.60
195.33
770.65
9
 Net Profit (7-8)
730.07
289.17
1486.90
579.92
1954.06
10
 Paid- up Equity Share Capital (Face value of Rs. 10 each)
3238.19
2799.92
3238.19
2799.92
3238.19
11
 Reserves excluding Revaluation Reserves
-
-
36990.13
12
 Basic & Diluted Earnings per Share (Rs.)
2.25*
1.03*
4.59*
2.07*
6.61

13

 

 Aggregate of Non-Promoter Shareholding      
  -No of equity shares of Rs. 10/-each
27552762
23413322
27552762
23413322
27640677
  -Percentage of Shareholding
85.09
83.62
85.09
83.62
85.36
* EPS is for the period (not annualised)
   
 
SEGMENT WISE REVENUE, RESULTS AND CAPITAL EMPLOYED
(Rs.Lakhs)
Particulars
Three months ended
September 30, 2003
Three months ended
September 30, 2002
Six months ended
September 30, 2003
Six months ended
September 30, 2002
Year ended March 31, 2003
1. Segment Revenue        
a. Bulk
13911.40
10279.32
29214.09
20004.05
50066.25
b. Formulations
2803.08
1452.25
5584.81
2638.76
6346.07
Total
16714.48
11731.57
34798.90
22642.81
56412.32
Less: Inter segment revenue
531.16
598.31
1323.51
826.05
2270.89
Net Sales / Income from Operations
16183.32
11133.26
33475.39
21816.76
54141.43
 
 
2. Segment Results: (Profit/(Loss) before interest & tax)
a. Bulk
2570.45
1172.48
4211.97
2369.08
7315.15
b. Formulations
(25.63)
179.04
211.58
165.48
(452.40)
Total
2544.82
1351.52
4423.55
2534.56
6862.75
 
Less: i) Interest (Net)
1660.88
1032.99
2769.58
1789.61
4207.69
ii) Other unallocable expenditure net of unallocable income
(14.69)
(27.70)
(64.58)
(30.30)
(69.65)
Total Profit Before Tax
898.63
346.23
1718.55
775.25
2724.71
 
3. Capital Employed
a. Bulk
121420.47
75540.53
121420.47
75540.53
98935.81
b. Formulations
9561.58
4202.84
9561.58
4202.84
9350.00
Total
130982.05
79743.37
130982.05
79743.37
108285.81
 
  • The above financial results were taken on record by the Board of Directors at its meeting held on Friday, October 31, 2003
  • Previous period figures have been regrouped, wherever necessary.
  • The Company received 38 complaints during the three months ended September 30, 2003 from the shareholders and all the complaints have been resolved and no complaints were pending as on September 30, 2003.

Place : Chennai
Date : 31-October-2003

For and on behalf of the Board

K.Raghavendra Rao
Managing Director